PULMOBIOMED LTD

Active Newcastle Upon Tyne

Research and experimental development on biotechnology

8 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
P

PULMOBIOMED LTD

Research and experimental development on biotechnology

Founded 9 Apr 2020 Active Newcastle Upon Tyne, United Kingdom 8 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 27 Nov 2025 Next due 31 Jan 2027 7 months remaining
Confirmation Submitted 12 Jun 2025 Next due 26 Jun 2026 16 days remaining
Net assets £405K £745K 2025 year on year
Total assets £1M £86K 2025 year on year
Total Liabilities £753K £659K 2025 year on year
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

Rmt Accountants & Business Advisors Ltd Gosforth Park Avenue Newcastle Upon Tyne NE12 8EG United Kingdom

Telephone

0800 000 0000

Website

www.example.com

Full company profile for PULMOBIOMED LTD (12552857), an active life sciences and medical technology company based in Newcastle Upon Tyne, United Kingdom. Incorporated 9 Apr 2020. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 May → 30 Apr 2025
Type total-exemption-full
Next accounts 30 Apr 2026
Due by 31 Jan 2027 7 months remaining

Net Assets, Total Assets & Total Liabilities (2021–2025)

Cash in Bank

£740.95k

Decreased by £337.46k (-31%)

Net Assets

£405.22k

Decreased by £745.29k (-65%)

Total Liabilities

£753.16k

Increased by £659.38k (+703%)

Turnover

N/A

Employees

8

Increased by 4 (+100%)

Debt Ratio

65%

Increased by 57 (+713%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
30 Apr Year End
2024
30 Apr Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1
Grants 1

Investors (4)

Investor NameInvestor SinceParticipating Rounds
Investor 1Feb 2024Seed
Investor 2Feb 2024Seed
Investor 3Feb 2024Seed

Share Capital

Share Capital

Share allotments and capital structure

5 Allotments 5,344,810 Shares £2.13m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
18 Jan 2024172,872£45k£0.26
14 Dec 20235,077,424£1.32m£0.26
14 Dec 202384,515£22k£0.26
2 Dec 20208,499£722k£84.99
2 Dec 20201,500£23k£15

Officers

Officers

2 active 1 resigned
Status
Sterghios MoschosDirectorGreekUnited Kingdom479 Apr 2020Active
Trevor Michael PhillipsDirectorBritishUnited Kingdom6527 May 2025Active

Shareholders

Shareholders (14)

Sterghios Moschos
31.7%
University Of Northumbria
26.0%

Persons with Significant Control

Persons with Significant Control (2)

2 Active

University Of Northumbria At Newcastle

United Kingdom

Active
Notified 2 Dec 2020
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

Sterghios Moschos

Greek

Active
Notified 9 Apr 2020
Residence United Kingdom
DOB January 1979
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

Group Structure

Group Structure

No group structure identified

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
27 Nov 2025AccountsAnnual accounts made up to 30 Apr 2025
12 Jun 2025Confirmation StatementConfirmation statement made on 12 Jun 2025 with no updates
6 Jun 2025Persons With Significant ControlChange to Dr Sterghios Moschos as a person with significant control on 13 Dec 2023
2 Jun 2025OfficersTermination of Huw Alun Edwards as director on 1 Jun 2025
1 Jun 2025OfficersTermination of Peter Martin Hotten as director on 1 Jun 2025
27 Nov 2025 Accounts

Annual accounts made up to 30 Apr 2025

12 Jun 2025 Confirmation Statement

Confirmation statement made on 12 Jun 2025 with no updates

6 Jun 2025 Persons With Significant Control

Change to Dr Sterghios Moschos as a person with significant control on 13 Dec 2023

2 Jun 2025 Officers

Termination of Huw Alun Edwards as director on 1 Jun 2025

1 Jun 2025 Officers

Termination of Peter Martin Hotten as director on 1 Jun 2025

Recent Activity

Latest Activity

Annual accounts made up to 30 Apr 2025

6 months ago on 27 Nov 2025

Confirmation statement made on 12 Jun 2025 with no updates

12 months ago on 12 Jun 2025

Change to Dr Sterghios Moschos as a person with significant control on 13 Dec 2023

1 years ago on 6 Jun 2025

Termination of Huw Alun Edwards as director on 1 Jun 2025

1 years ago on 2 Jun 2025

Termination of Peter Martin Hotten as director on 1 Jun 2025

1 years ago on 1 Jun 2025